vs
NCS Multistage Holdings, Inc.（NCSM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NCS Multistage Holdings, Inc.的1.4倍（$69.8M vs $50.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 29.5%，领先354.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 12.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.4%）
NCS Multistage Holdings是一家全球能源技术与油田服务提供商，主营油气勘探生产用的完井系统与多级压裂工具，服务覆盖北美、拉美、中东及亚太市场，助力上游能源客户提升作业效率与资源采收率。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NCSM vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$50.6M
营收增速更快
RIGL
高出8.7%
12.5%
净利率更高
RIGL
高出354.5%
29.5%
两年增速更快
RIGL
近两年复合增速
7.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $50.6M | $69.8M |
| 净利润 | $15.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 10.3% | 33.2% |
| 净利率 | 29.5% | 384.0% |
| 营收同比 | 12.5% | 21.2% |
| 净利润同比 | 331.0% | 1769.2% |
| 每股收益（稀释后） | $5.43 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCSMRIGL
| Q4 25 | $50.6M | $69.8M | ||
| Q3 25 | $46.5M | $69.5M | ||
| Q2 25 | $36.5M | $101.7M | ||
| Q1 25 | $50.0M | $53.3M | ||
| Q4 24 | $45.0M | $57.6M | ||
| Q3 24 | $44.0M | $55.3M | ||
| Q2 24 | $29.7M | $36.8M | ||
| Q1 24 | $43.9M | $29.5M |
净利润NCSMRIGL
| Q4 25 | $15.0M | $268.1M | ||
| Q3 25 | $3.8M | $27.9M | ||
| Q2 25 | $924.0K | $59.6M | ||
| Q1 25 | $4.1M | $11.4M | ||
| Q4 24 | $3.5M | $14.3M | ||
| Q3 24 | $4.1M | $12.4M | ||
| Q2 24 | $-3.1M | $-1.0M | ||
| Q1 24 | $2.1M | $-8.2M |
毛利率NCSMRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率NCSMRIGL
| Q4 25 | 10.3% | 33.2% | ||
| Q3 25 | 6.6% | 40.9% | ||
| Q2 25 | -5.6% | 60.1% | ||
| Q1 25 | 8.6% | 23.9% | ||
| Q4 24 | 6.5% | 28.9% | ||
| Q3 24 | 6.9% | 25.4% | ||
| Q2 24 | -14.0% | 1.2% | ||
| Q1 24 | 5.7% | -23.6% |
净利率NCSMRIGL
| Q4 25 | 29.5% | 384.0% | ||
| Q3 25 | 8.2% | 40.2% | ||
| Q2 25 | 2.5% | 58.6% | ||
| Q1 25 | 8.1% | 21.5% | ||
| Q4 24 | 7.7% | 24.9% | ||
| Q3 24 | 9.4% | 22.5% | ||
| Q2 24 | -10.4% | -2.8% | ||
| Q1 24 | 4.7% | -27.9% |
每股收益（稀释后）NCSMRIGL
| Q4 25 | $5.43 | $14.11 | ||
| Q3 25 | $1.37 | $1.46 | ||
| Q2 25 | $0.34 | $3.28 | ||
| Q1 25 | $1.51 | $0.63 | ||
| Q4 24 | $1.34 | $0.82 | ||
| Q3 24 | $1.60 | $0.70 | ||
| Q2 24 | $-1.21 | $-0.06 | ||
| Q1 24 | $0.82 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.7M | $155.0M |
| 总债务越低越好 | $5.3M | $52.5M |
| 股东权益账面价值 | $126.2M | $391.5M |
| 总资产 | $181.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.04× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NCSMRIGL
| Q4 25 | $36.7M | $155.0M | ||
| Q3 25 | $25.3M | $137.1M | ||
| Q2 25 | $25.4M | $108.4M | ||
| Q1 25 | $23.0M | $77.1M | ||
| Q4 24 | $25.9M | $77.3M | ||
| Q3 24 | $15.3M | $61.1M | ||
| Q2 24 | $18.6M | $49.1M | ||
| Q1 24 | $14.0M | $49.5M |
总债务NCSMRIGL
| Q4 25 | $5.3M | $52.5M | ||
| Q3 25 | $5.1M | $60.0M | ||
| Q2 25 | $5.5M | $60.0M | ||
| Q1 25 | $5.4M | $60.0M | ||
| Q4 24 | $6.0M | $60.0M | ||
| Q3 24 | $6.5M | $60.0M | ||
| Q2 24 | $6.8M | $60.0M | ||
| Q1 24 | $6.4M | $60.0M |
股东权益NCSMRIGL
| Q4 25 | $126.2M | $391.5M | ||
| Q3 25 | $110.1M | $117.6M | ||
| Q2 25 | $106.4M | $81.9M | ||
| Q1 25 | $103.2M | $18.6M | ||
| Q4 24 | $98.8M | $3.3M | ||
| Q3 24 | $96.0M | $-14.6M | ||
| Q2 24 | $91.0M | $-29.9M | ||
| Q1 24 | $93.7M | $-31.7M |
总资产NCSMRIGL
| Q4 25 | $181.2M | $513.6M | ||
| Q3 25 | $162.0M | $242.5M | ||
| Q2 25 | $158.0M | $206.7M | ||
| Q1 25 | $155.1M | $176.0M | ||
| Q4 24 | $152.8M | $164.0M | ||
| Q3 24 | $145.8M | $139.4M | ||
| Q2 24 | $139.4M | $128.4M | ||
| Q1 24 | $140.9M | $126.5M |
负债/权益比NCSMRIGL
| Q4 25 | 0.04× | 0.13× | ||
| Q3 25 | 0.05× | 0.51× | ||
| Q2 25 | 0.05× | 0.73× | ||
| Q1 25 | 0.05× | 3.23× | ||
| Q4 24 | 0.06× | 18.25× | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.08× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $12.9M | — |
| 自由现金流率自由现金流/营收 | 25.5% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | 0.88× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $21.0M | — |
8季度趋势，按日历期对齐
经营现金流NCSMRIGL
| Q4 25 | $13.1M | $22.0M | ||
| Q3 25 | $7.2M | $24.0M | ||
| Q2 25 | $3.5M | $30.5M | ||
| Q1 25 | $-1.6M | $-893.0K | ||
| Q4 24 | $10.6M | $14.5M | ||
| Q3 24 | $-2.0M | $21.7M | ||
| Q2 24 | $6.0M | $302.0K | ||
| Q1 24 | $-1.9M | $-5.0M |
自由现金流NCSMRIGL
| Q4 25 | $12.9M | — | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $3.2M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $10.4M | — | ||
| Q3 24 | $-2.5M | — | ||
| Q2 24 | $5.6M | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率NCSMRIGL
| Q4 25 | 25.5% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 8.9% | — | ||
| Q1 25 | -4.2% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | -5.6% | — | ||
| Q2 24 | 19.0% | — | ||
| Q1 24 | -5.0% | — |
资本支出强度NCSMRIGL
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
现金转化率NCSMRIGL
| Q4 25 | 0.88× | 0.08× | ||
| Q3 25 | 1.88× | 0.86× | ||
| Q2 25 | 3.81× | 0.51× | ||
| Q1 25 | -0.41× | -0.08× | ||
| Q4 24 | 3.07× | 1.01× | ||
| Q3 24 | -0.49× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NCSM
| Products | $33.8M | 67% |
| Services | $16.8M | 33% |
RIGL
暂无分部数据
